Remove 2025 Remove Diabetes Remove Internal Medicine Remove Management
article thumbnail

ADA: Weight Loss, Type 2 Diabetes Remission Up With Replacing Diet Drinks With Water

Physician's Weekly

WEDNESDAY, June 25, 2025 (HealthDay News) — For adult women with overweight or obesity and type 2 diabetes (T2D), replacing diet beverages (DBs) with water is associated with greater weight loss and T2D remission, according to a study presented at the annual meeting of the American Diabetes Association, held from June 20 to 23 in Chicago.

article thumbnail

Practice tip of the week: Hiring a marketing consultant

Physician's Practice

Recent Videos Related Content Schrödinger's Cat: Financial perils of Allograft diabetic ulcer grafts Martin Merritt, Esq. June 17th 2025 Article Health care practices face rising audits and recoupments for using placental membrane grafts in diabetic ulcer treatments, risking significant financial penalties.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Insurers Promise to Speed Up Delays in Health Care Approvals

Physician's Weekly

WEDNESDAY, June 25, 2025 (HealthDay News) — Getting approval from your insurance company before a procedure or treatment may soon get a little easier. SOURCE: NBC News , June 23, 2025 Copyright © 2025 HealthDay. Health and Human Services Secretary Robert F. Kennedy Jr. All rights reserved.

article thumbnail

Pearls profiles: Get to know Neil Baum, MD

Physician's Practice

He has written ten books on practice management and the business of medicine. Each tightly produced episode offers a front-row seat to the personalities, real-world experience and quick-hit advice behind our most popular practice management columns.

52
article thumbnail

Deprescribing Super Special III: Constance Fung, Emily McDonald, Amy Linsky, and Michelle Odden

GeriPal

In our third segment, we explore Amy Linskys study that examined the effect of patient-directed educational materials on clinician deprescribing of potentially low-benefit or high-risk medications, such as proton pump inhibitors, high-dose gabapentin, or risky diabetes medications. And so those are all options that are available.

article thumbnail

Endocrinology, Diabetes and Metabolism Board Meeting Summary | Spring 2025

ABIM

Christine Twining, MD, Chair, ABIM Endocrinology, Diabetes and Metabolism Board The Endocrinology, Diabetes and Metabolism Board , which meets twice a year and is responsible for oversight of policy and assessment in the specialty, held its spring meeting on April 1, 2025. The following is a summary of the spring meeting.

article thumbnail

Caring for the Unrepresented: A Podcast with Joe Dixon, Timothy Farrell, Yael Zweig

GeriPal

And so there’s complexity in Understanding how each state manages this. So on the clinical side, people are really focused on how long do they have to be on the ventilator and managing that. So you mentioned the burden of chronic multimorbidity and sort of flogging through the diabetes and the hypertension.